The 15 references in paper A. Shishkin N., N. Hudiakova V., N. Temnaja V., А. Шишкин Н., Н. Худякова В., Н. Темная В. (2014) “Микроальбуминурия при метаболических нарушениях у женщин в перименопаузе // Microalbuminuria and metabolic disorders in perimenopausal women” / spz:neicon:nefr:y:2014:i:1:p:62-67

1
Ford ES. The metabolic syndrome and mortality from cardiovascular disease and all-causes: Findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 2004 (173): 309–314
(check this in PDF content)
2
Wang. Z, Wang FF, Zhu XJ et al. Metabolic syndrome and microalbuminuria accompanied with hyperglycemia in community subjects. Zhonghua Yi Xue Za Zhi 2012 Sep 25; 92(36): 2526-2529
(check this in PDF content)
3
El Azeem HA, Khalek el-SA, El-Akabawy H et al. Association between nonalcoholic fatty liver disease and the incidence of cardiovascular and renal events. J Saudi Heart Assoc 2013 Oct; 25 (4): 239-246
(check this in PDF content)
4
Michalakis K, Mintziori G, Kaprara A et al. The complex interaction between obesity, metabolic syndrome and reproductive axis: a narrative review. Metabolism 2013 Apr; 62 (4): 457-478
(check this in PDF content)
5
Иванов НВ, Сильницкий ПА, Ворохобина НВ. Нарушения репродуктивной функции у мужчин с метаболическим синдромом. Балтийский журнал современной эндокринологии 2011; (2): 98-105
(check this in PDF content)
6
Singh AK, Kari JA. Metabolic syndrome and chronic kidney disease. Curr Opin Nephrol Hypertens 2013 Mar; 22(2): 198-203
(check this in PDF content)
7
Chen J, Muntner P, Hamm LL et al. The metabolic syndrome and chronic kidney disease in U. S. adults. Ann Intern Med 2004;140 (3): 167–174
(check this in PDF content)
8
Ryu S, Chang Y, Woo HY et al. Time-dependent association between metabolic syndrome and risk of CKD in Korean men without hypertension or diabetes. Am J Kidney Dis 2009; 53(1): 59-69
(check this in PDF content)
9
Yang T, Chu CH, Hsu CH et al. Impact of metabolic syndrome on the incidence of chronic kidney disease: a Chinese cohort study. Nephrology (Carlton) 2012;17(6):532-538
(check this in PDF content)
10
Пчелин ИЮ, Шишкин АН, Лаптева ОА. Роль системного и локального воспаления в развитии диабетической нефропатии. Нефрология 2011; 15 (4): 21-26
(check this in PDF content)
11
Alberti КG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; (15): 539-553
(check this in PDF content)
12
Scott M, Grundy MD, Becker D et al. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of Hight Blood Cholesterolin Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of hight blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002 (106): 3143-3421
(check this in PDF content)
13
Jarraya F, Lakhdar R, Kammoun K et al. Microalbuminuria A Useful Marker of Cardiovascular Disease. Iranian Journal of Kidney Diseases 2013 May;7 (3):178-186
(check this in PDF content)
14
Aaron R. Folsom. Classical and Novel Biomarkers for Cardiovascular Risk Prediction in the United States. J Epidemiol 2013; 23(3):158-162.
(check this in PDF content)
15
Добронравов ВА, Смирнов АВ, Каюков ИГ. Многогранная микроальбуминурия: аспекты клинического значения. Нефрология 2009; 13 (3); 33-38 16 Шишкин АН, Худякова НВ, Смирнов ВВ. Менопаузальный метаболический синдром. Современные представления.
(check this in PDF content)